Clonitazene
Systematic (IUPAC) name | |
---|---|
2-[2-[(4-chlorophenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine | |
Clinical data | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 3861-76-5 |
ATC code | none |
PubChem | CID 62528 |
DrugBank | DB01523 |
ChemSpider | 56301 |
UNII | S90R21A2V2 |
ChEMBL | CHEMBL2104616 |
Synonyms | Clonitazene |
Chemical data | |
Formula | C20H23ClN4O2 |
Molar mass | 386.88 g/mol |
| |
| |
(verify) |
Clonitazene is an opioid analgesic of approximately three times the potency of morphine. It is related to etonitazene, an opioid of significantly higher potency. Clonitazene is not currently marketed. It is a controlled substance; in the United States it is a Schedule I Narcotic controlled substance with a DEA ACSCN of 9612 and an annual manufacturing quota of zero.
Synthesis
References
- ↑ Hunger, A.; Kebrle, J.; Rossi, A.; Hoffmann, K. (1957). "Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate". Experientia 13 (10): 400–1. doi:10.1007/BF02161116. PMID 13473817.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.